Correlation Between AC Immune and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both AC Immune and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AC Immune and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AC Immune and AN2 Therapeutics, you can compare the effects of market volatilities on AC Immune and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AC Immune with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AC Immune and AN2 Therapeutics.
Diversification Opportunities for AC Immune and AN2 Therapeutics
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between ACIU and AN2 is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding AC Immune and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and AC Immune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AC Immune are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of AC Immune i.e., AC Immune and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between AC Immune and AN2 Therapeutics
Given the investment horizon of 90 days AC Immune is expected to generate 0.85 times more return on investment than AN2 Therapeutics. However, AC Immune is 1.18 times less risky than AN2 Therapeutics. It trades about 0.01 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 379.00 in AC Immune on August 25, 2024 and sell it today you would lose (41.00) from holding AC Immune or give up 10.82% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
AC Immune vs. AN2 Therapeutics
Performance |
| Timeline |
| AC Immune |
| AN2 Therapeutics |
AC Immune and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AC Immune and AN2 Therapeutics
The main advantage of trading using opposite AC Immune and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AC Immune position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| AC Immune vs. Pmv Pharmaceuticals | AC Immune vs. Eliem Therapeutics | AC Immune vs. MediciNova | AC Immune vs. Pharvaris BV |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |